Table 2.
Continue Summary of Demography and Baseline Characteristics
| Variable (s) | Before Matching | After Matching | ||||||
|---|---|---|---|---|---|---|---|---|
| Overall (N=941) | Positive (N=846) | Negative (N=95) | P-value | Overall (N=212) | Positive (N=159) | Negative (N=53) | P-value | |
| Comorbidities | ||||||||
| Hypertension | 557 (60.7) | 505 (61.2) | 52 (55.9) | 0.3214^^ | 140 (66.4) | 107 (67.7) | 33 (62.3) | 0.4669^^ |
| Diabetes Mellitus | 563 (61.3) | 507 (61.5) | 56 (60.2) | 0.8160^^ | 138 (65.4) | 107 (67.7) | 31 (58.5) | 0.2215^^ |
| Dyslipidemia | 194 (21.1) | 179 (21.7) | 15 (16.1) | 0.2125^^ | 47 (22.3) | 42 (26.6) | 5 (9.4) | 0.0094^^ |
| Heart Failure | 91 (9.9) | 83 (10.1) | 8 (8.6) | 0.6555^^ | 23 (10.9) | 20 (12.7) | 3 (5.7) | 0.1572^^ |
| Asthma | 60 (6.5) | 54 (6.5) | 6 (6.5) | 0.9723^^ | 8 (3.8) | 5 (3.2) | 3 (5.7) | 0.4104** |
| COPD | 24 (2.6) | 23 (2.8) | 1 (1.1) | 0.3265** | 10 (4.7) | 10 (6.3) | 0 (0.0) | 0.0606** |
| Chronic kidney disease (CKD) | 142 (15.5) | 129 (15.6) | 13 (14.0) | 0.6751^^ | 33 (15.6) | 29 (18.4) | 4 (7.5) | 0.0609^^ |
| Cancer | 62 (6.8) | 55 (6.7) | 7 (7.5) | 0.7540^^ | 10 (4.7) | 7 (4.4) | 3 (5.7) | 0.7153** |
| Liver disease (any type) | 26 (2.8) | 26 (3.2) | 0 (0.0) | 0.0824** | 5 (2.4) | 5 (3.2) | 0 (0.0) | 0.1900** |
Notes: *t-Test / ^ Wilcoxon rank sum test is used to calculate the P-value. ^^ Chi-square test / Fisher exact test is used to calculate the P-value.